Enhancing Capital LLC Purchases New Position in The Clorox Company (NYSE:CLX)

Enhancing Capital LLC purchased a new position in The Clorox Company (NYSE:CLX - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 2,000 shares of the company's stock, valued at approximately $325,000.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Advisors Asset Management Inc. boosted its holdings in Clorox by 43.4% in the third quarter. Advisors Asset Management Inc. now owns 29,865 shares of the company's stock worth $4,865,000 after acquiring an additional 9,037 shares in the last quarter. Natixis Advisors LLC lifted its holdings in shares of Clorox by 8.3% during the third quarter. Natixis Advisors LLC now owns 63,476 shares of the company's stock valued at $10,341,000 after purchasing an additional 4,839 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its holdings in shares of Clorox by 1.8% during the third quarter. Charles Schwab Investment Management Inc. now owns 723,906 shares of the company's stock valued at $117,932,000 after purchasing an additional 13,038 shares in the last quarter. Public Employees Retirement System of Ohio lifted its holdings in shares of Clorox by 26.3% during the third quarter. Public Employees Retirement System of Ohio now owns 59,766 shares of the company's stock valued at $9,736,000 after purchasing an additional 12,428 shares in the last quarter. Finally, Fifth Third Wealth Advisors LLC bought a new position in shares of Clorox during the fourth quarter valued at $204,000. 78.53% of the stock is owned by hedge funds and other institutional investors.

Remove Ads

Clorox Stock Performance

CLX traded down $0.46 during midday trading on Friday, reaching $144.88. The company had a trading volume of 1,553,392 shares, compared to its average volume of 1,208,595. The company has a quick ratio of 0.60, a current ratio of 0.94 and a debt-to-equity ratio of 20.52. The business has a 50-day moving average of $152.84 and a two-hundred day moving average of $159.77. The company has a market cap of $17.85 billion, a P/E ratio of 39.58, a P/E/G ratio of 2.62 and a beta of 0.45. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $171.37.

Clorox (NYSE:CLX - Get Free Report) last issued its quarterly earnings results on Monday, February 3rd. The company reported $1.55 EPS for the quarter, topping analysts' consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same period in the previous year, the business earned $2.16 earnings per share. As a group, equities research analysts predict that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Wednesday, April 23rd will be given a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a dividend yield of 3.37%. The ex-dividend date of this dividend is Wednesday, April 23rd. Clorox's dividend payout ratio is currently 133.33%.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on CLX shares. StockNews.com downgraded Clorox from a "buy" rating to a "hold" rating in a report on Sunday, January 5th. JPMorgan Chase & Co. upped their price target on Clorox from $171.00 to $173.00 and gave the company a "neutral" rating in a report on Tuesday, February 4th. Wells Fargo & Company upped their price target on Clorox from $157.00 to $161.00 and gave the company an "equal weight" rating in a report on Tuesday, February 4th. Royal Bank of Canada reaffirmed a "sector perform" rating and set a $150.00 price target on shares of Clorox in a report on Thursday, January 30th. Finally, Evercore ISI increased their target price on Clorox from $145.00 to $155.00 in a report on Tuesday, February 4th. Three equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has issued a buy rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus price target of $159.62.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.